Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • FEBRUARY 2020 Issue has been successfully launched on 1 February 2020.

  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level



*Ram S. Pentewar, Dr. Sanjay S. Thonte, Rohit U. Bharti, R. V. Sugave, V. Garud


The buccal region offers an attractive route of administration for systemic drug delivery. The mucosa has a rich blood supply and provides rapid absorption for drugs than oral route. The Levosalbutamol sulphate is a β adreno-receptor agonist used for the maintenance, treatment of chronic asthma attacks and to relieve Chronic obstructive pulmonary diseases (COPD) Because of poor bioavailability of Levosalbutamol sulphate by oral route, there is a need to increase its bioavailability by formulating it into buccal dosage forms. The main objective of study was to formulate and evaluate buccal tablets of Levosalbutamol sulphate. The tablets were prepared by direct compression method. The tablets were evaluated based on their physical characteristics like, weight variation, thickness, hardness; their mechanical properties are found within the prescribed limits. Swelling index of all the formulations were between ranges of 18.56±0.55 to 89.31±0.07. Surface pH, friability, like in vitro residence time and their evaluations like, drug content uniformity are found within the ranges, the ranges of (F7- F12) and in vitro study shows drug release from 71.25% to 99.24%, among these the formulation (F8) shown highest drug release of 99.24±1.00% at the end of 8 hours. The FTIR study reveals that there was no interaction between API and excipients. It was observed that all preformulation and formulation parameters were acceptable with reasonable limits of standards required for buccal tablets which may enhance the absorption of drug with increased residence time in buccal cavity avoiding first pass metabolism also may leads to increased bioavailability.

Keywords: Levosalbutamol sulphate, Chitosan, xanthan gum, ethyl cellulose, Mucoadhesive drug delivery System.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More